Published in Int J Methods Psychiatr Res on January 01, 2007
Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry (2009) 3.56
Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl) (2009) 1.76
Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry (2010) 1.68
The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med (2008) 1.59
Clinical reappraisal of the Composite International Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). Int J Methods Psychiatr Res (2013) 1.22
A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS One (2012) 1.13
Sleep disturbance, circadian preference and symptoms of adult attention deficit hyperactivity disorder (ADHD). J Neural Transm (Vienna) (2012) 0.94
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res (2013) 0.89
Externalizing Outcomes of Youth with and without ADHD: Time-Varying Prediction by Parental ADHD and Mediated Effects. J Abnorm Child Psychol (2016) 0.88
Alcohol and drug use among adolescents: and the co-occurrence of mental health problems. Ung@hordaland, a population-based study. BMJ Open (2014) 0.87
Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Atten Defic Hyperact Disord (2014) 0.86
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86
Parenting Behavior Mediates the Intergenerational Association of Parent and Child Offspring ADHD Symptoms. J Clin Child Adolesc Psychol (2014) 0.85
Protocol: Personality assessment as a support for referral and case-work in treatment for substance use disorders (PASRC-study). BMC Psychiatry (2008) 0.83
ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Ups J Med Sci (2010) 0.80
Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review. Prim Care Companion CNS Disord (2012) 0.80
The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. J Clin Psychiatry (2012) 0.79
History of reading struggles linked to enhanced learning in low spatial frequency scenes. PLoS One (2012) 0.79
Mental health in adolescents with Type 1 diabetes: results from a large population-based study. BMC Endocr Disord (2014) 0.79
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey. BMC Psychiatry (2016) 0.79
Attention Deficit Hyperactivity Disorder Symptoms, Comorbidities, Substance Use, and Social Outcomes among Men and Women in a Canadian Sample. Biomed Res Int (2015) 0.78
Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants. Clin Pract Epidemiol Ment Health (2012) 0.78
Boys with Asperger Syndrome Grow Up: Psychiatric and Neurodevelopmental Disorders 20 Years After Initial Diagnosis. J Autism Dev Disord (2016) 0.78
Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry (2013) 0.78
Attention Deficit/Hyperactivity Disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study. PLoS One (2014) 0.78
Psychiatric Comorbidity, Social Aspects and Quality of Life in a Population-Based Cohort of Expecting Fathers with Epilepsy. PLoS One (2015) 0.78
Naturalistic Pharmacotherapy Compliance among Pediatric Patients with Attention Deficit/Hyperactivity Disorder: a Study Based on Three-Year Nationwide Data. J Korean Med Sci (2016) 0.78
Adult attention deficit hyperactivity disorder and violence in the population of England: does comorbidity matter? PLoS One (2013) 0.77
The Adult ADHD Self-Report Scale (ASRS): utility in college students with attention-deficit/hyperactivity disorder. PeerJ (2014) 0.77
The use of research measures in adult clinical practice. Innov Clin Neurosci (2011) 0.77
Association of screen time with self-perceived attention problems and hyperactivity levels in French students: a cross-sectional study. BMJ Open (2016) 0.76
A brief report on the relationship between self-control, video game addiction and academic achievement in normal and ADHD students. J Behav Addict (2013) 0.76
Prevalence of and associated factors for adult attention deficit hyperactivity disorder in young Swiss men. PLoS One (2014) 0.75
Frequency of structural brain abnormalities among adult diagnosed with Attention - Deficit/Hyperactivity Disorder. Glob J Health Sci (2013) 0.75
Relationship of attention-deficit/hyperactivity disorder symptom severity with severity of alcohol-related problems in a sample of inpatients with alcohol use disorder. Neuropsychiatr Dis Treat (2016) 0.75
Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients. BMC Psychiatry (2017) 0.75
The structure of adult ADHD. Int J Methods Psychiatr Res (2017) 0.75
The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employment. Eur J Epidemiol (2016) 0.75
The Effectiveness of Parent Training as a Treatment for Preschool Attention-Deficit/Hyperactivity Disorder: Study Protocol for a Randomized Controlled, Multicenter Trial of the New Forest Parenting Program in Everyday Clinical Practice. JMIR Res Protoc (2016) 0.75
Use of neuroenhancement drugs: prevalence, frequency and use expectations in Switzerland. Int J Environ Res Public Health (2014) 0.75
Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys? Child Adolesc Psychiatry Ment Health (2016) 0.75
The role of parental psychopathology and personality in adolescent non-suicidal self-injury. J Psychiatr Res (2016) 0.75
Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students. Neuropsychiatr Dis Treat (2015) 0.75
Asperger syndrome in childhood - personality dimensions in adult life: temperament, character and outcome trajectories. BJPsych Open (2016) 0.75
Differences in Perceived Mental Effort Required and Discomfort during a Working Memory Task between Individuals At-risk And Not At-risk for ADHD. Front Psychol (2017) 0.75
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men. Addiction (2016) 0.75
Longitudinal Smoking Patterns: Do They Predict Symptoms of ADHD in Adults? J Atten Disord (2015) 0.75
The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry (2017) 0.75
Personality disorders and Axis I comorbidity in adolescent outpatients with ADHD. BMC Psychiatry (2016) 0.75
Predictive models for suicidal thoughts and behaviors among Spanish University students: rationale and methods of the UNIVERSAL (University & mental health) project. BMC Psychiatry (2016) 0.75
Psychometrically Informed Approach to Integration of Multiple Informant Ratings in Adult ADHD in a Community-Recruited Sample. Assessment (2016) 0.75
Alcohol and Illicit Drug Use Are Important Factors for School-Related Problems among Adolescents. Front Psychol (2017) 0.75
Impact of obsessive-compulsive personality disorder symptoms in Internet users. Ann Clin Psychiatry (2017) 0.75
Economic volatility in childhood and subsequent adolescent mental health problems: a longitudinal population-based study of adolescents. BMJ Open (2017) 0.75
Validity and Reliability of Adult ADHD Self-Report Scale Thai Version (ASRS-V1.1 TH). Shanghai Arch Psychiatry (2017) 0.75
Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency. PLoS One (2017) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res (2004) 29.02
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA (2004) 22.38
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med (2005) 5.81
Variance estimation for complex surveys using replication techniques. Stat Methods Med Res (1996) 3.96
Parent and child contributions to diagnosis of mental disorder: are both informants always necessary? J Am Acad Child Adolesc Psychiatry (1999) 3.33
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry (2003) 2.66
Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 2.21
What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord (2005) 2.16
Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med (2005) 2.09
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08
Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures. Arch Gen Psychiatry (1988) 2.03
Adults with ADHD. An overview. Ann N Y Acad Sci (2001) 1.97
The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med (2005) 1.83
Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry (2000) 1.70
A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1995) 1.59
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry (1998) 1.53
Integrating stratum-specific likelihood ratios with the analysis of ROC curves. Med Decis Making (1993) 1.40
Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol (1992) 1.37
Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess (2002) 1.37
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry (2005) 1.25
Adult ADHD. Analysis of self-ratings on a behavior questionnaire. Ann N Y Acad Sci (2001) 1.21
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res (2006) 1.17
Diagnosing ADD-H in adolescents. Psychopharmacol Bull (1985) 1.04
Assessing the concordance of measures used to diagnose adult ADHD. J Atten Disord (2007) 0.95
The prevalence of attention deficit disorders in a rural midwestern community sample of nine-year-old children. J Am Acad Child Psychiatry (1985) 0.91
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry (2007) 6.46
The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med (2005) 5.81
Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry (2010) 5.53
Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2007) 4.98
Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry (2011) 4.03
National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry (2009) 3.92
Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Int J Methods Psychiatr Res (2009) 3.81
The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med (2003) 3.78
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med (2006) 3.57
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry (2008) 3.52
Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br J Psychiatry (2010) 3.38
National comorbidity survey replication adolescent supplement (NCS-A): II. Overview and design. J Am Acad Child Adolesc Psychiatry (2009) 3.31
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87
Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res (2010) 2.81
Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication II: associations with persistence of DSM-IV disorders. Arch Gen Psychiatry (2010) 2.77
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry (2003) 2.66
Network homogeneity reveals decreased integrity of default-mode network in ADHD. J Neurosci Methods (2007) 2.56
Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36
Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. Arch Gen Psychiatry (2012) 2.32
Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry (2010) 2.31
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry (2006) 2.03
The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry (2005) 2.03
Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend (2006) 1.98
Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry (2003) 1.91
Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry (2006) 1.89
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.87
The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med (2005) 1.83
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.81
Weight management using the internet a randomized controlled trial. Am J Prev Med (2008) 1.76
Mental health service use among hurricane Katrina survivors in the eight months after the disaster. Psychiatr Serv (2007) 1.73
Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biol Psychiatry (2006) 1.73
Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol (2009) 1.70
The prevalence and correlates of DSM-IV disorders in the Iraq Mental Health Survey (IMHS). World Psychiatry (2009) 1.68
Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population. Circ Cardiovasc Qual Outcomes (2010) 1.68
Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry (2010) 1.68
The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy (2007) 1.64
Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. Biol Psychiatry (2005) 1.62
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr (2009) 1.60
Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol (2005) 1.50
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2004) 1.49
Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry (2012) 1.49
Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med (2010) 1.48
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry (2008) 1.41
Food insecurity and mental disorders in a national sample of U.S. adolescents. J Am Acad Child Adolesc Psychiatry (2012) 1.38
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr (2006) 1.35
Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 1.34
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol (2009) 1.32
Serious emotional disturbance among youths exposed to Hurricane Katrina 2 years postdisaster. J Am Acad Child Adolesc Psychiatry (2009) 1.31
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2004) 1.26
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry (2006) 1.24
School mental health resources and adolescent mental health service use. J Am Acad Child Adolesc Psychiatry (2013) 1.24
Clinical reappraisal of the Composite International Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). Int J Methods Psychiatr Res (2013) 1.22
Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict (2007) 1.22
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend (2008) 1.21
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics (2009) 1.20
Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics (2003) 1.18
Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol (2006) 1.17
Disruption of existing mental health treatments and failure to initiate new treatment after Hurricane Katrina. Am J Psychiatry (2007) 1.16
Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry (2010) 1.15
Trends in serious emotional disturbance among youths exposed to Hurricane Katrina. J Am Acad Child Adolesc Psychiatry (2010) 1.14
Severity of the aggression/anxiety-depression/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2012) 1.12
Statistical models in assessing fold change of gene expression in real-time RT-PCR experiments. Comput Biol Chem (2006) 1.09
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr (2005) 1.09
Role of referrals in mental health service disparities for racial and ethnic minority youth. J Am Acad Child Adolesc Psychiatry (2012) 1.08
Complicated grief associated with hurricane Katrina. Depress Anxiety (2011) 1.06
Validation of the adult ADHD investigator symptom rating scale (AISRS). J Atten Disord (2009) 1.05
Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct (2005) 1.05
Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med (2006) 1.04
Recovery from PTSD following Hurricane Katrina. Depress Anxiety (2011) 1.04
An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol (2005) 1.04
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. J Clin Psychopharmacol (2004) 1.04
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2003) 1.03
Attention deficit hyperactivity disorder: concordance of the adolescent version of the Composite International Diagnostic Interview Version 3.0 (CIDI) with the K-SADS in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement. Int J Methods Psychiatr Res (2010) 1.03
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2011) 1.03
Training raters to assess adult ADHD: reliability of ratings. J Atten Disord (2005) 1.03
Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry (2004) 1.02
Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry (2011) 1.01
Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHD. J Atten Disord (2007) 1.01
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord (2009) 1.00
Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2005) 0.99
Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet (2008) 0.99
Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks. Psychiatry Res (2011) 0.97
Stability of executive function deficits in girls with ADHD: a prospective longitudinal followup study into adolescence. Dev Neuropsychol (2008) 0.97
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry (2008) 0.97
The clinical characteristics of unipolar vs. bipolar major depression in ADHD youth. J Affect Disord (2004) 0.96
An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr (2006) 0.95
A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2010) 0.95
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord (2007) 0.95
Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder. Psychiatry Res (2009) 0.94
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr (2007) 0.93
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol (2013) 0.93
Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population. Am J Addict (2010) 0.93
ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry (2005) 0.92
Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry (2005) 0.91